TrialMedical physics2026

Evaluation of AI-derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial.

Libing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.